Skip to main content
TipRanks
Go Ultimate75% OFF

BioMarin Pharmaceutical (BM8) Q1 2023 Earnings Report

1 Followers

DE:BM8 Q1 2023 EPS Results

Actual EPS
EUR 0.25
Consensus EPS
EUR 0.14
Beat/Miss
Beat by +EUR 0.10
One Year Ago EPS
EUR 0.57

DE:BM8 Q1 2023 Revenue Results

Actual Revenue
EUR 540.75M
Expected Revenue
EUR 520.15M
Beat/Miss
Beat by +EUR 20.60M
YoY Revenue Growth
+15.41%

Earnings Announcement Details

Quarter
Q1 2023
Date
04/26/2023
Time
After Close
Conference Call
Wednesday, April 26, 2023
DE:BM8 Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q1 2023 Earnings Call Audio

DE:BM8 Q1 2023 Earnings Call
0:00 / 0:00

Q1 2023 Earnings Slide Deck

Q1 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:BM8 Earnings History

DE:BM8 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)0.75--0.22――
Nov 02, 20262026 (Q3)-0.040.21-0.15243.75% (+0.36)
Aug 06, 20262026 (Q2)0.861.091.12-2.44% (-0.03)
May 04, 20262026 (Q1)0.630.690.87-20.00% (-0.17)
Feb 23, 20262025 (Q4)0.15-0.220.58-137.50% (-0.80)
Oct 27, 20252025 (Q3)-0.26-0.150.5-129.09% (-0.65)
Aug 04, 20252025 (Q2)0.791.120.5123.64% (+0.62)
May 01, 20252025 (Q1)0.650.870.42106.52% (+0.45)
Feb 19, 20252024 (Q4)0.490.580.1481.82% (+0.48)
Oct 29, 20242024 (Q3)0.480.500.19161.90% (+0.31)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed